⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

January 1, 2026Nanoscale

Nanocarrier-empowered aggregation-induced luminescence and its therapeutic promise in oncology

Y. X. Li Lin Geng Yilin Han Shuo Wang Pu Liu Weifeng Jiang

View Full Paper

Ask AI

Bookmark

Share

Key Points

The aim is to explore challenges in using aggregation-induced emission (AIE) agents and their combination with nanocarriers for cancer treatment.
Systematic review of existing literature on AIEgen applications and challenges.
Analysis of biocompatibility and safety issues associated with AIEgens in vivo.
Evaluation of strategies to improve AIEgen effectiveness using nanocarrier technology.
Identified significant limitations in current AIEgen applications for oncology.
Proposed solutions involving nanocarriers to enhance biocompatibility and safety.
Recommended strategies indicate promising pathways for therapeutic advancements.

Implication

This review explores strategies for improving biocompatibility of AIEgens in oncology through nanocarriers, suggesting therapeutic potential.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Li et al. (2026) studied this question.

synapsesocial.com/papers/69db37254fe01fead37c51bd https://doi.org/10.1039/d5nr04932f

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Aggregation-Induced Emission (AIE) Probe-Labeled Nanotheranostics: A Mini-ReviewReview · 2026 · 1 citations
2Illuminating the Unseen and Targeting the Untreatable: Aggregation‐Induced Emission Nanoparticles as Intelligent, Immune‐Compatible Tools for Precision Cancer Theranostics2025 · 11 citations
3Aggregation‐Induced Emission Luminogens (AIEgens): From Intrinsic Therapeutic Effect to Sensitization of Conventional Antitumor ModalitiesReview · 2026
4Intelligent Theranostic Systems Enabled by Aggregation‐Induced Emission in Precision Medicine2025 · 18 citations
5From challenges to solutions: insights into AIEgen-based diagnostic and therapeutic strategies for breast cancerReview · 2026